NEBULA

Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Dec 2025)

What this means for you

This application is over — abandoned 15 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
98390865
Mark type
Stylized text
Filed
04 Feb 2024
Published for opposition
17 Sept 2024
Abandoned
15 Dec 2025

Goods and services

  • Class 001 — Chemicals: Chemical, biological, and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological cell cultures for scientific research purposes and not for medical or veterinary purposes; chemical products, namely, chemical additives for use in separation processes for biological materials; chemical, biochemical, and diagnostic reagents for non-medical scientific and medical research laboratory use, namely, for use in cell separation, labeling chemical, biochemical, and diagnostic reagents, cell culture media for growing cells, tempering substances, and chemical and protein ingredients for the preparation of media; chemical, biochemical, and diagnostic reagents for non-medical scientific purposes for the processing, separation, isolation, enrichment, transduction, transfection, depletion, detection, screening, analysis, and counting of materials, namely, chemical materials and biological materials, especially biological cells; chemical, biochemical, and diagnostic reagents for non-medical scientific purposes with magnetic beads; antibody reagents with fluorescent molecules used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; chemical preparations for scientific purposes, namely, chemical buffer solutions and chemical reagents for use with laboratory instruments, especially separation instruments, analysis instruments, and reactor instruments; reagents for scientific purposes, namely, for processing of biological material, especially tissue, bone marrow, cells, and blood and its components, other than for medical or veterinary purposes; diagnostic reagents and diagnostic preparations for scientific purposes and for use in medical research laboratories; biological tissue cell culture media, cell culture media, and cryogenic chemical preparations for scientific purposes, namely, for use in the freezing of genetic and blood tissue; chemical, biochemical, and diagnostic reagents for non-medical scientific purposes, namely, for use in biotechnology, in biological treatment processes, and in the biotechnology industry
  • Class 005 — Pharmaceuticals: Reagents for medical and veterinary use, namely, for the processing, separation, isolation, enrichment, transduction, transfection, depletion, detection, screening, analysis, and counting of material, especially of biological materials and biological cells; reagents with magnetic beads for medical and veterinary use; antibody reagents used for the detection of antigens in cells and tissue for medical purposes; disinfectants for medical instruments in the nature of buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, and reactor instruments; reagents for medical and veterinary use, namely, for the processing of biological material, especially tissue, bone marrow, cells, and blood and its components; culture media for cultivating human, animal, and microorganism cells for medical purposes; diagnostic reagents and diagnostic preparations for medical and veterinary purposes; cryopreservation cell freezing media for medical and veterinary purposes; pharmaceutical products, namely, pharmaceutical preparations for the cellular therapy treatment of cancer, autoimmunity, infection, inflammation, tissue-based diseases, and immunological, dermatological, and neurological diseases; chemical, biological, and biochemical products for therapeutic and diagnostic purposes, namely, diagnostic preparations made from chemicals and biochemicals for medical purposes for the treatment of cancer, autoimmunity, and dermatological, neurological, and cardiovascular diseases

Owner

Prosecution history

  • 15 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 15 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
  • 25 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 25 Apr 2025 — SOU EXTENSION 1 GRANTED
  • 24 Apr 2025 — SOU EXTENSION 1 FILED
  • 24 Apr 2025 — SOU TEAS EXTENSION RECEIVED
  • 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 17 Sept 2024 — PUBLISHED FOR OPPOSITION
  • 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 09 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 09 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 09 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 03 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy